TY - JOUR
T1 - Cross-sectional association between metabolic parameters and psychotic-like experiences in a population-based sample of middle-aged and elderly individuals
AU - Çakici, Nuray
AU - Grootendorst-van Mil, Nina H.
AU - Roza, Sabine J.
AU - Tiemeier, Henning
AU - de Haan, Lieuwe
AU - Ikram, M. Arfan
AU - Voortman, Trudy
AU - Luik, Annemarie I.
AU - van Beveren, Nico J. M.
N1 - Funding Information:
The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University , Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science , the Ministry for Health, Welfare and Sports , the European Commission (DG XII), and the Municipality of Rotterdam . N. Çakici was funded by an unrestricted personal grant to NJM. van Beveren by Parnassia Group , Center for Mental Health Care . L. de Haan was funded by AmsterdamUMC . These funding sources had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the paper for publication.
Publisher Copyright:
© 2023 The Authors
PY - 2023/11/1
Y1 - 2023/11/1
N2 - Background: Metabolic alterations are often found in patients with clinical psychosis early in the course of the disorder. Psychotic-like experiences are observed in the general population, but it is unclear whether these are associated with markers of metabolism. Methods: A population-based cohort of 1890 individuals (mean age 58.0 years; 56.3% women) was included. Metabolic parameters were measured by body-mass index (BMI), concentrations of low-density and high-density lipoprotein cholesterol (LDL-C and HDL-C), total cholesterol, triglycerides, and fasting glucose and insulin in blood. Frequency and distress ratings of psychotic-like experiences from the positive symptom dimension of the Community Assessment of Psychic Experience questionnaire were assessed. Cross-sectional associations were analysed using linear regression analyses. Results: Higher BMI was associated with higher frequency of psychotic-like experiences (adjusted mean difference: 0.04, 95% CI 0.02–0.06) and more distress (adjusted mean difference: 0.02, 95% CI 0.01–0.03). Lower LDL-C was associated with more psychotic-like experiences (adjusted mean difference: −0.23, 95% CI −0.40 to −0.06). When restricting the sample to those not using lipid-lowering medication, the results of BMI and LDL-C remained and an association between lower HDL-C and higher frequency of psychotic-like experiences was found (adjusted mean difference: −0.37, 95% CI −0.69 to −0.05). We observed no significant associations between cholesterol, triglycerides, glucose, insulin or homeostatic model assessment and psychotic-like experiences. Conclusions: In a population-based sample of middle-aged and elderly individuals, higher BMI and lower LDL-C were associated with psychotic-like experiences. This suggests that metabolic markers are associated with psychotic-like experiences across the vulnerability spectrum.
AB - Background: Metabolic alterations are often found in patients with clinical psychosis early in the course of the disorder. Psychotic-like experiences are observed in the general population, but it is unclear whether these are associated with markers of metabolism. Methods: A population-based cohort of 1890 individuals (mean age 58.0 years; 56.3% women) was included. Metabolic parameters were measured by body-mass index (BMI), concentrations of low-density and high-density lipoprotein cholesterol (LDL-C and HDL-C), total cholesterol, triglycerides, and fasting glucose and insulin in blood. Frequency and distress ratings of psychotic-like experiences from the positive symptom dimension of the Community Assessment of Psychic Experience questionnaire were assessed. Cross-sectional associations were analysed using linear regression analyses. Results: Higher BMI was associated with higher frequency of psychotic-like experiences (adjusted mean difference: 0.04, 95% CI 0.02–0.06) and more distress (adjusted mean difference: 0.02, 95% CI 0.01–0.03). Lower LDL-C was associated with more psychotic-like experiences (adjusted mean difference: −0.23, 95% CI −0.40 to −0.06). When restricting the sample to those not using lipid-lowering medication, the results of BMI and LDL-C remained and an association between lower HDL-C and higher frequency of psychotic-like experiences was found (adjusted mean difference: −0.37, 95% CI −0.69 to −0.05). We observed no significant associations between cholesterol, triglycerides, glucose, insulin or homeostatic model assessment and psychotic-like experiences. Conclusions: In a population-based sample of middle-aged and elderly individuals, higher BMI and lower LDL-C were associated with psychotic-like experiences. This suggests that metabolic markers are associated with psychotic-like experiences across the vulnerability spectrum.
KW - BMI
KW - Epidemiology
KW - Lipids
KW - Metabolism
KW - Psychosis continuum
KW - Subclinical psychosis
UR - https://www.scopus.com/pages/publications/85172375791
U2 - 10.1016/j.schres.2023.09.008
DO - 10.1016/j.schres.2023.09.008
M3 - Article
C2 - 37757577
SN - 0920-9964
VL - 261
SP - 145
EP - 151
JO - Schizophrenia research
JF - Schizophrenia research
ER -